CIK 0001699031 · Non-accelerated filer<br>Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863673636
- Phone
- (833) 694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- 4 Open-market sale President sold 48,213 shares at $33.93 ($1,635,867)
- 4 Open-market sale Chief Financial Officer sold 41,150 shares at $33.93 ($1,396,220)
- 4 Open-market sale Chief Executive Officer sold 94,035 shares at $33.93 ($3,190,608)
- 4 Grant or award Director acquired 784 shares (grant or award)
- 4 Grant or award Director acquired 760 shares (grant or award)
- 4 Grant or award Director acquired 1,212 shares (grant or award)
- 4/A Open-market sale Chief Financial Officer sold 1,816 shares at $31.20 ($56,659)
- 4/A Open-market sale Chief Executive Officer sold 7,625 shares at $31.21 ($237,976)
- 4/A Open-market sale President sold 2,109 shares at $31.20 ($65,801)
- 4 Open-market sale Chief Executive Officer sold 7,625 shares at $31.21 ($237,976)
- 4 Open-market sale President sold 2,109 shares at $31.20 ($65,801)
- 4 Open-market sale Chief Financial Officer sold 1,816 shares at $31.20 ($56,659)
- 4 Open-market sale Chief Financial Officer sold 521 shares at $41.51 ($21,627)
- 4 Open-market sale President sold 525 shares at $41.51 ($21,793)
- 4 Open-market sale Chief Executive Officer sold 994 shares at $41.51 ($41,261)
- 4 Grant or award Chief Financial Officer acquired 69,230 shares (grant or award)
- 4 Grant or award President acquired 110,770 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 224,620 shares (grant or award)
- 4 Grant or award Director acquired 1,182 shares (grant or award)
- 4 Grant or award Director acquired 1,147 shares (grant or award)
Page 4 of 6 · 115 filings